Delivery Order SPE2DB22D1106-SPE2DB24FEYD6

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 10,000 unit vials of the pharmaceutical product Pregnyl. The contract has a ceiling value of $1,255.56 and a performance period through March 27, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp,...
This federal contract award, valued at $2,388.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pregnyl 10,000 unit vials, a medical product used for various therapeutic purposes. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,035.22, is for the delivery of 10,000 unit vials of the pharmaceutical product Pregnyl. The contract is a firm fixed price delivery order with an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This federal contract award, valued at $4,784.39, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,415,725 units of Pregnyl 10,000 unit vials, a pharmaceutical product. The contract has an ultimate completion date of October 10, 2023 and is a firm fixed-price delivery order. The contract was awarded on October 6, 2023 and does not have a set-aside designation,...
This federal contract award, SPE2DB22D1106|SPE2DB25FEAV3, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not designated as a set-aside, has a ceiling value of $1,221.35 and covers the delivery of 10,000 unit vials of the drug Pregnyl. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
The Defense Logistics Agency awarded a $1,270.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 10,000 unit vials of PregnyL. The order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen. Performance will take place in Conshohocken, Pennsylvania from August 14-15, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports military readiness by procuring, managing...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,017.45, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 21, 2024. The award was made on February 20, 2024, and there was no set-aside...
This federal contract award is for the delivery of the pharmaceutical product GONAL-F RFF REDI-JECT 900 UNIT 1.5ML to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $15,594.00, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 2, 2024 and was awarded on August 1, 2024. This delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $975,187.24 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract, with a performance period ending on January 13, 2025, is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred seventy dollars to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 10,000 unit vials of PREGNYL to be delivered to a location in Conshohocken, Pennsylvania by October 13, 2023. No set-aside designation was applied to this requirement. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this contract supports the Defense...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEYD6
    Delivery Order

This federal contract award is for the delivery of 4,564,972,551 units of Pregnyl 10,000 unit vials to the Defense Logistics Agency (DLA). The $2,388.96 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through June 24, 2024.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that larger IDC with the DLA, which enables efficient government procurement of essential medical commodities for military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 10:02 AM